NO944419D0 - Derivater av dolastatin - Google Patents

Derivater av dolastatin

Info

Publication number
NO944419D0
NO944419D0 NO944419A NO944419A NO944419D0 NO 944419 D0 NO944419 D0 NO 944419D0 NO 944419 A NO944419 A NO 944419A NO 944419 A NO944419 A NO 944419A NO 944419 D0 NO944419 D0 NO 944419D0
Authority
NO
Norway
Prior art keywords
dolastatin
derivatives
novel
derivates
formula
Prior art date
Application number
NO944419A
Other languages
English (en)
Other versions
NO310465B1 (no
NO944419L (no
Inventor
Andreas Haupt
Franz Emling
Cynthia Romerdahl
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO944419D0 publication Critical patent/NO944419D0/no
Publication of NO944419L publication Critical patent/NO944419L/no
Publication of NO310465B1 publication Critical patent/NO310465B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO19944419A 1992-05-20 1994-11-18 Peptider med anticancer aktivitet og farmasöytisk blanding derav NO310465B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88578892A 1992-05-20 1992-05-20
US98569692A 1992-11-25 1992-11-25
PCT/EP1993/001138 WO1993023424A1 (en) 1992-05-20 1993-05-10 Derivatives of dolastatin

Publications (3)

Publication Number Publication Date
NO944419D0 true NO944419D0 (no) 1994-11-18
NO944419L NO944419L (no) 1995-01-09
NO310465B1 NO310465B1 (no) 2001-07-09

Family

ID=27128772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19944419A NO310465B1 (no) 1992-05-20 1994-11-18 Peptider med anticancer aktivitet og farmasöytisk blanding derav

Country Status (21)

Country Link
EP (1) EP0642530B1 (no)
JP (2) JP3523253B2 (no)
KR (1) KR100286242B1 (no)
CN (1) CN1065874C (no)
AT (1) ATE169637T1 (no)
AU (1) AU669710B2 (no)
CA (1) CA2136339C (no)
CZ (1) CZ292612B6 (no)
DE (1) DE69320339T2 (no)
DK (1) DK0642530T3 (no)
ES (1) ES2118955T3 (no)
FI (1) FI120692B (no)
HU (2) HUT71398A (no)
IL (1) IL105651A (no)
MX (1) MX9302927A (no)
NO (1) NO310465B1 (no)
NZ (1) NZ252147A (no)
RU (1) RU2116312C1 (no)
SI (1) SI9300267A (no)
UA (1) UA45304C2 (no)
WO (1) WO1993023424A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
DE4415997A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neuer peptidischer Wirkstoff und dessen Herstellung
DE4415998A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neue Tetrapeptide, ihre Herstellung Verwendung
DE19527574A1 (de) * 1995-07-28 1997-01-30 Basf Ag Verfahren zur Herstellung vona-(N,N-Dialkyl)-aminocaarbonsäureamiden
DE19527575A1 (de) * 1995-07-28 1997-01-30 Basf Ag Verfahren zur Herstellung von peptidischer Wirkstoffe
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
AU775090B2 (en) * 1995-12-15 2004-07-15 Abbvie Deutschland Gmbh & Co Kg Antineoplastic peptides
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US5741892A (en) * 1996-07-30 1998-04-21 Basf Aktiengesellschaft Pentapeptides as antitumor agents
US5939527A (en) * 1996-07-30 1999-08-17 Basf Aktiengesellschaft Tetrapeptides as antitumor agents
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
DE69829881T2 (de) * 1997-09-24 2006-03-09 Arizona Board Of Regents, Tempe Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung
US6686445B1 (en) 1997-09-24 2004-02-03 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
DE60324964D1 (de) 2002-07-15 2009-01-08 Univ Princeton Iap-bindende verbindungen
ES2251894T3 (es) 2003-11-24 2009-04-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Procedimiento de purificacion de pravastatina.
WO2023033129A1 (ja) 2021-09-03 2023-03-09 東レ株式会社 癌の治療及び／又は予防用医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
ATE215962T1 (de) * 1991-08-09 2002-04-15 Teikoku Hormone Mfg Co Ltd Tetrapeptide derivat

Also Published As

Publication number Publication date
NO310465B1 (no) 2001-07-09
CN1065874C (zh) 2001-05-16
JP3523253B2 (ja) 2004-04-26
CZ292612B6 (cs) 2003-11-12
UA45304C2 (uk) 2002-04-15
HUT71398A (en) 1995-11-28
CA2136339C (en) 2008-02-05
FI945416A0 (fi) 1994-11-17
IL105651A (en) 1998-07-15
SI9300267A (sl) 1993-12-31
DE69320339T2 (de) 1998-12-17
FI120692B (fi) 2010-01-29
ES2118955T3 (es) 1998-10-01
DE69320339D1 (de) 1998-09-17
CN1085563A (zh) 1994-04-20
EP0642530B1 (en) 1998-08-12
AU4066293A (en) 1993-12-13
AU669710B2 (en) 1996-06-20
MX9302927A (es) 1993-11-01
EP0642530A1 (en) 1995-03-15
RU2116312C1 (ru) 1998-07-27
FI945416A (fi) 1994-11-17
DK0642530T3 (da) 1998-10-26
JPH07506580A (ja) 1995-07-20
HU211745A9 (en) 1995-12-28
WO1993023424A1 (en) 1993-11-25
NO944419L (no) 1995-01-09
NZ252147A (en) 1996-10-28
RU94046434A (ru) 1996-10-27
CZ284394A3 (en) 1995-05-17
ATE169637T1 (de) 1998-08-15
CA2136339A1 (en) 1993-11-25
KR100286242B1 (ko) 2001-04-16
JP2004149538A (ja) 2004-05-27
IL105651A0 (en) 1993-09-22

Similar Documents

Publication Publication Date Title
NO944419D0 (no) Derivater av dolastatin
MY124487A (en) Dolastatin derivatives, their preparation and use
FI952961A0 (fi) Dolostatiinianalogeja
JPS6429362A (en) 3-demethylmevalonic acid derivative
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
FI930051A0 (fi) 4,13-dioxabicyklo(8.2.1)tridecenonderivat sam foerfarande och mellanprodukt foer deras framstaellning
BG98238A (en) Substituted benzothiazole derivatives, methods for their preparation and their application as herbicides
FI971462A0 (fi) Bentsisoksatsolijohdannaisia ja niitä sisältäviä torjuntaainekoostumuksia
DE69012619D1 (de) Bis(1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-amin-derivate und stabilisierte Zusammensetzungen.
DK242089A (da) Anvendelse af pyrimido oe6,1-aaa-isoquinolin-4-on-derivater til hindring af haaraffald og foroegelse af haarvaekst
MY114327A (en) Novel peptides, the preparation and use thereof
RU1809521C (ru) Генератор плазмы
RU1821413C (ru) Летательный аппарат
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
EP0529444A3 (en) 2-arylpropenic acids and their utilisation in the preparation of 5-ketoprofen
AU4863993A (en) Tetrahydroindazolone pharmaceutical compositions
TH14157EX (th) เฟนิลเบนแซมีดสำหรับฆ่าราและกรรมวิธีสำหรับเตรียมสารนั้น
IT8821384A0 (it) 5 pirimidincarbossamidi sostituite e composizioni farmaceutiche contenenti le stesse per il trattamento di leucemia.

Legal Events

Date Code Title Description
MK1K Patent expired